R&D cost reflected to medical insurance drug prices
Published: 2000-03-27 17:00:00
Updated: 2000-03-27 17:00:00
In the top executive meeting of the KPMA it was agreed that the R&D cost for a new drug development should be reflected to the medical drug insurance price so that the company could return their heavy investment as early as possible.
The early investment return even for a modified new product ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
